EXELIXIS, INC. — Director's Dealing 2017

Apr 19, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2017-04-17

Reporting Person: Schwab Gisela (Pres Prod Dev & Med Aff & CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-04-17	Common Stock	M	10090	$9.91	Acquired	168143	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-04-17	Option (right to buy)	$9.91	M	10090	Disposed	2017-12-05	Common Stock (10090.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	14186	Indirect

Footnotes

F1: The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2017.

F2: Represents 14,186 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of April 17, 2017.

F3: The option, representing the right to purchase a total of 200,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2011.